CALLA: Efficacy and safety of durvalumab with and following concurrent chemoradiotherapy (CCRT) versus CCRT alone in women with locally advanced cervical cancer: A phase Ill, randomized, double-blind, multicenter study.-MedSci.cn

CALLA: Efficacy and safety of durvalumab with and following concurrent chemoradiotherapy (CCRT) versus CCRT alone in women with locally advanced cervical cancer: A phase Ill, randomized, double-blind, multicenter study.

Monk, BJ; Mayadev, J; Nunes, AT; Brown, AD; Marcovitz, M; Lanasa, MC

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

科室
- - 订阅+
  - 更多科室
工具
服务